Naturally Splendid Enterprises Ltd V.NSP.H

How not to do it

[angel334]

Have to admit I was surprised by Rocks post that Q3 bulk sales may come in below Q2 due to hemp shortage. Up to that I was expecting (like Spaceman and possibly others on this Board) that Q3 would be at least at level of Q2 or even better. Anyway, I am not so much concerned about this issue as it appears to be a temporary glitch especially now that they have the money to buy inventory. However, I hope that NSP will address the issue properly in their communication of the Q3 financials. I had a similar experience with Vanc Pharmaceuticals (NPH.V). The Company is building a generics pharma business. Q1 sales were o.k., expectation on the bullboard was that Q2 sales would be clearly better (there was even a competition on the board to accurately estimate the Q2 sales figure). Then they posted their Q2 results on SEDAR: Revenue fell sequentially by about 50%. On page 6 of their MD&A you could find the following explanation: "The reduction in gross revenue in Q2 2016 in comparison to Q1 2016 was caused by the out of stock of one of the most popular product." That was it. No further explanation, no press release, nothing. Quite understandably, the share price tanked. I hope NSP will avoid this mistake and put in whatever little effort and time is required to communicate the issue properly (if it turns out as expected by Rock). But then again, maybe it does not matter this much anymore given our changed sharehoolder structure ;-) (as also stated in some posts on this board). GLTA Angel